Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Ocular Therapeutix, Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 216 | 6 | 249 | +39 |
| Shares | 188.2M | 960.7K | 191.6M | +4.33M (+2.3%) |
| Value | $2.20B | $11.2M | $2.33B | +$136.3M (+6.2%) |
6 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (59)
Institutions that held Ocular Therapeutix, Inc at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (20)
Institutions that held Ocular Therapeutix, Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Eventide Asset Management, LLC | 598,000 | $6.99M |
| Driehaus Capital Management LLC | 518,754 | $6.06M |
| Centiva Capital, LP | 250,000 | $2.92M |
| Affinity Asset Advisors, LLC | 239,000 | $2.79M |
| Cantor Fitzgerald, L. P. | 201,865 | $2.36M |
| Macquarie Group Ltd | 174,389 | $2.04M |
| ExodusPoint Capital Management, LP | 163,132 | $1.91M |
| Maven Securities LTD | 100,000 | $1.17M |
| Hudson Bay Capital Management LP | 50,039 | $585.0K |
| Harbert Fund Advisors, Inc. | 50,000 | $584.5K |
| Two Sigma Securities, LLC | 17,088 | $199.8K |
| Levin Capital Strategies, L.P. | 15,000 | $175.3K |
| Vontobel Holding Ltd. | 14,498 | $169.5K |
| Dudley & Shanley, Inc. | 13,000 | $152.0K |
| Axq Capital, LP | 11,517 | $134.6K |
| Marex Group plc | 10,000 | $116.9K |
| Quarry LP | 6,870 | $80.3K |
| Advisory Services Network, LLC | 636 | $7.43K |
| Bessemer Group Inc | 151 | $2.00K |
| Clearstead Advisors, LLC | 35 | $410 |
Not filed for Q4 2025 yet (6)
Institutions that held Ocular Therapeutix, Inc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 466,179 | $5.45M |
| AXA Investment Managers S.A. | 439,881 | $5.14M |
| Point72 (DIFC) Ltd | 32,643 | $381.6K |
| CIBC Bancorp USA Inc. | 14,985 | $175.2K |
| Point72 Europe (London) LLP | 5,825 | $68.1K |
| Point72 Asia (Singapore) Pte. Ltd. | 1,216 | $14.2K |